Operator compression with deep neural networks.

This paper studies the compression of partial differential operators using neural networks. We consider a family of operators, parameterized by a potentially high-dimensional space of coefficients that may vary on a large range of scales. Based on the existing methods that compress such a multiscale operator to a finite-dimensional sparse surrogate model on a given target scale, we propose to directly approximate the coefficient-to-surrogate map with a neural network. We emulate local assembly structures of the surrogates and thus only require a moderately sized network that can be trained efficiently in an offline phase. This enables large compression ratios and the online computation of a surrogate based on simple forward passes through the network is substantially accelerated compared to classical numerical upscaling approaches. We apply the abstract framework to a family of prototypical second-order elliptic heterogeneous diffusion operators as a demonstrating example.

The Medical Devices Special Access Program in Canada: A Scoping Study.

New health technologies enter Canadian healthcare organizations in various ways, and understanding them is essential to the development of a pan-Canadian Health Technology Management (HTM) Strategy, now a priority of governments across Canada. One way is through Health Canada's Medical Devices Special Access Program (MDSAP), which permits unlicensed devices to be obtained by healthcare professionals. However, the circumstances around and implications of the current use of this program are not clear. A scoping literature review was conducted to clarify these and identify important roles and issues related to the MDSAP. Limited information was found on the MDSAP. Nevertheless, three themes demonstrating the roles of the MDSAP in HTM emerged: arbiter in technology selection, a route to technology procurement and facilitator of health technology innovation. No information suggesting that MDSAP is used to circumvent licensing was found. Rather, it enables desired patient outcomes and product commercialization.

An empirical study of early childhood support through partnership building.

The first five years were recognized as a critical period of child growth. Accordingly, California voters approved tobacco tax through Proposition 10 to fund early childhood services since 1998. Due to the state revenue decline, Service Integration has been advocated to enhance program supports in Child Health, Family Functioning, and Child Development. In this study, interview data are analyzed to examine the partnership building among 40 programs. The results indicate a significant impact of the service outreach across remote communities in Kern County, California. In addition, contextual information is provided to facilitate interpretation of the partnership strength from a social network analysis. Enhancement of this investigation is discussed in light of future development.

Overall survival and extent of surgery in adult versus elderly glioblastoma patients: A population based retrospective study.

INTRODUCTION: The purpose of this retrospective population based study was to investigate the effect of the extent of surgery on overall survival in young versus adult glioblastoma patients in Vorarlberg/Austria during the last 4 years. METHODS: Forty-eight patients (median age 62.5 years, ranging from 25-82 years, 19 female and 29 male) with histologically proven glioblastoma received surgery (16 biopsies, 18 partial and 14 complete resections) and postoperative chemo-irradiation with concomitant and adjuvant temozolomide. The median follow up of the patient population was 11.7 months (ranging from 3 to 36 months). Postoperative temporary morbidity was found in 5 out of 48 (10.4%) patients, and no mortality or permanent morbidity occurred. One infection led to revision surgery. FINDINGS: Altogether, the 12/24 months overall survival was 54/20.2% with a median survival of 13.7 months. In younger patients (<65 yrs, median 57.5 yrs, 28 patients), the 12/24 months overall survival was 68.4/34.3% with 16.9 months median survival, in the elderly patients (>65 yrs, median 73 yrs, 20 patients) the 12/24 months overall survival was 28.8/5.8%, with 7.7 months median survival (Log-rank, p = 0.0005). Extent of surgery influenced overall survival of the adult group nearly significantly (biopsy versus complete resection: p = 0.06), but did not affect overall survival of the elderly (p = 0.5). CONCLUSIONS: Overall survival of elderly glioblastoma patients treated with surgery and chemo-irradiation with concomitant and adjuvant temozolomide is significantly reduced compared to the younger patients. In addition, in the elderly the extent of surgery did not influence the prognosis in our population.